Cell Image Analysis Artificial Intelligence (AI) Market Report 2026

Cell Image Analysis Artificial Intelligence (AI) Market Overview

• Cell Image Analysis Artificial Intelligence (AI) market size has reached to $2.01 billion in 2025 • Expected to grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 24.2% • Growth Driver: Rising Pharmaceutical Investments Fueling The Growth Of The Market Due To Increasing Funding For High-content Imaging And Drug Discovery • Market Trend: Innovations In Artificial Intelligence (AI) Technology Enhance Advanced Cell Morphology Analysis And Cross-Geography Data Collaboration • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell Image Analysis Artificial Intelligence (AI) Market?

Cell image analysis artificial intelligence (AI) refers to the application of machine learning and Computer Vision algorithms to automatically interpret, classify, and quantify microscopic cell images with high speed and precision. Its purpose is to enhance accuracy, reduce manual analysis time, and generate actionable biological insights for research, diagnostics, and drug development. The main components of the cell image analysis artificial intelligence (AI) market include software, hardware, and services. Software refers to AI platforms and tools used for analyzing cellular images, performing segmentation, classification, and pattern recognition. The deployment modes include on-premises and cloud and finds applications in drug discovery, disease diagnosis, cell classification, image segmentation, and other applications. The key end-users include pharmaceutical and biotechnology companies, academic and research institutes, hospitals and diagnostic laboratories, and others.

What Is The Cell Image Analysis Artificial Intelligence (AI) Market Growth Forecast?

The cell image analysis artificial intelligence (ai) market size is expected to see exponential growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 24.2%. The growth in the forecast period can be attributed to growth of personalized medicine applications, increasing integration of ai in diagnostic workflows, rising adoption of cloud-based platforms, expansion of high-throughput screening, growing use of predictive analytics in pharmaceutical research. Major trends in the forecast period include rising adoption of gpu-enabled workstations for image analysis, increasing use of multiplex and high-content imaging analytics, growth in cloud-based cell image analysis platforms, expansion of automated quality control and validation services, rising demand for technical consulting and ai model training services.

Global Cell Image Analysis Artificial Intelligence (AI) Market Segmentation

1) By Component: Software, Hardware, Services 2) By Deployment Mode: On-Premises, Cloud 3) By Application: Drug Discovery, Disease Diagnosis, Cell Classification, Image Segmentation, Other Applications 4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Hospitals And Diagnostic Laboratories, Other End-Users Subsegments: 1) By Hardware: Robot Arms and Manipulators, Collaborative Robots (Cobots), End-Effectors and Grippers, Sensors and Perception Hardware, Actuators and Drives, Machine Vision Systems, Controllers and PLCs, AGVs and AMRs, Safety Systems and Fencing, Power and Cabling Infrastructure 2) By Software: Robot Operating Systems and Firmware, Simulation and Digital-Twin Software, Motion Planning and Path Optimization, AI and Machine Learning Software, Vision and Perception Software, Cell and Fleet Management Software, MES or ERP Integration Software, Predictive Maintenance and Analytics, Cybersecurity Software, Low-Code or No-Code Programming Tools 3) By Services: System Design and Engineering, Integration and Commissioning, Maintenance and Field Support, Training and Skill Development, Retrofit and Modernization Services, Custom Application Development, Robotics-as-a-Service (RaaS), Validation and Testing Services, Consulting and ROI Analysis, R&D and Co-innovation Services

What Is The Driver Of The Cell Image Analysis Artificial Intelligence (AI) Market?

The rising investments in pharmaceuticals are expected to propel the growth of the cell image analysis artificial intelligence (AI) market going forward. Investments in pharmaceuticals refer to the allocation of capital by companies, governments, and investors into drug discovery, clinical development, manufacturing, and advanced research technologies to develop new therapies and improve healthcare outcomes. Pharmaceutical investments are increasing primarily due to the growing global burden of chronic and complex diseases that demand continuous development of new and more effective therapies. Pharmaceutical investments fuel cell image analysis AI by funding high-content imaging, data infrastructure, and AI tool development needed to accelerate drug discovery, phenotypic screening, and cellular-level insights. For instance, in February 2025, according to the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), a Switzerland-based industry body representing research-based pharmaceutical companies and associations worldwide, the top 50 pharmaceutical companies collectively invested approximately USD 167 billion in R&D in 2022, with spending projected to grow at an annual rate of 6.7%, surpassing USD 200 billion by 2025. Therefore, the rising investments in pharmaceuticals are driving the growth of the cell image analysis artificial intelligence (AI) industry.

Key Players In The Global Cell Image Analysis Artificial Intelligence (AI) Market

Major companies operating in the cell image analysis artificial intelligence (AI) market are Danaher Corporation, Carl Zeiss AG, Lunit Inc, Deciphex Limited, OptraScan Inc, Proscia Inc, Deepcell Inc, Aignostics GmbH, Visiopharm A S, Indica Labs Inc, Ibex Medical Analytics Ltd, Deep Bio Inc, NucleAI Ltd, Reveal Biosciences Inc, TissueGnostics GmbH, ariadne AI AG, Vuno Inc, HistoIndex Pte Ltd, Aiforia Technologies Plc, and KOLAIDO GmbH.

Global Cell Image Analysis Artificial Intelligence (AI) Market Trends and Insights

Major companies operating in the cell image analysis artificial intelligence (AI) market are focusing on developing image analysis solutions, such as cloud‑hosted AI‑driven microscopy data platforms, to enable scalable processing of large microscopy datasets and accelerate accurate, real-time cellular insights across laboratories and research centers. Cloud-hosted AI-driven microscopy data platforms refer to online systems that store, process, and analyze large volumes of microscopy images using artificial intelligence, enabling remote access, scalable computing power, and collaborative analysis without local hardware limitations. For instance, in June 2025, ThinkCyte, a Japan‑based biotechnology company, launched MorphoScan Cloud, a cloud‑based platform designed for AI‑driven cell morphology data analysis that expands the capabilities of its VisionSort morphometric cell analysis system by enabling secure cloud storage, cross‑geography data sharing, and access to advanced analytical tools powered by deep learning for both supervised and unsupervised insights. MorphoScan Cloud’s architecture combines scalable cloud computing, integrated AI algorithms, and collaborative features to streamline workflows, reduce processing times, and empower research teams to derive deeper biological insights from complex cellular data without the limitations of local hardware, with applications in drug discovery, disease research, and cytometric studies.

What Are Latest Mergers And Acquisitions In The Cell Image Analysis Artificial Intelligence (AI) Market?

In October 2024, ChemoMetec A/S, a Denmark-based provider of cell counting instruments and analytical measurement solutions for life sciences and bioprocessing, acquired Ovizio Imaging Systems SA for approximately $3.1 million (€2.83 million). With this acquisition, ChemoMetec aimed to enhance its portfolio of cell analysis products by integrating Ovizio’s AI-enhanced holographic microscopy technology, thereby expanding into real-time, label-free imaging solutions for bioprocessing and cell therapy applications. Ovizio Imaging Systems SA is a Belgium-based provider of AI-enabled holographic microscopy-based cell analysis systems used for the continuous monitoring and counting of cells in bioreactors and research workflows.

Regional Insights

North America was the largest region in the cell image analysis artificial intelligence (AI) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell Image Analysis Artificial Intelligence (AI) Market?

The cell image analysis artificial intelligence (AI) market consists of revenues earned by entities by providing services such as behavior analysis, multiplex image analysis, quality control, validation of microscopy image datasets, and technical consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell image analysis artificial intelligence (AI) market also includes sales of storage systems, model training toolkits, whole-slide image viewers, and GPU-enabled workstations. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell Image Analysis Artificial Intelligence (AI) Market Report 2026?

The cell image analysis artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides cell image analysis artificial intelligence (AI) market statistics, including cell image analysis artificial intelligence (AI) industry global market size, regional shares, competitors with a cell image analysis artificial intelligence (AI) market share, detailed cell image analysis artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the cell image analysis artificial intelligence (AI) industry. This cell image analysis artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.